fbpx

NANEXA

Drug delivery company with a focus on the proprietary nano-based drug delivery platform PharmaShell®

Nanexa is a drug delivery company with an in-house developed and patented drug delivery platform, PharmaShell®, which is used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The PharmaShell process is based on ALD (Atomic Layer Deposition) technology, which encloses pharmaceutical particles with a thin shell and creates the opportunity for pharmaceutical companies to develop completely new pharmaceutical products. Nanexa currently collaborates with several pharmaceutical companies.

ANALYSER

ABOUT NANEXA

CEO: David Westberg

TICKER: NANEXA

LIST: First North 

WEB: https://nanexa.com/

CASE VIDEO SUMMARY

ANALYST

Johan Widmark

johan@emergers.se

+46739196641 

For new research on growth stocks, sign up to our newsletter